What is the Sarepta Therapeutics Inc. stock price forecast?

Sarepta Therapeutics Inc. is currently trading at $23.08. View real-time AI analysis on Alpha Lenz.

What is Sarepta Therapeutics Inc. insider trading activity?

View the latest insider trading data for Sarepta Therapeutics Inc. on Alpha Lenz.

What is Sarepta Therapeutics Inc.'s P/E ratio?

Sarepta Therapeutics Inc.'s P/E ratio is 9.3.

Sarepta Therapeutics Inc.

NASDAQ · SRPT

$23.08

Ask about Sarepta Therapeutics Inc.'s future dividend policy...

Alpha Chat Insight

“Sarepta Therapeutics Inc. trades at a P/E of 9.3 (undervalued) with strong ROE of 19.7%. 3Y revenue CAGR of 39.4% highlights clear growth momentum.”

Ask for details →

Company Overview

SectorUnknown

IndustryUnknown

Company Statistics

FY 2024

Profile

$2.19BMarket Cap

$1.90BRevenue

0.00Shares Out

N/AEmployees

Margins

83.22%Gross

17.07%EBITDA

11.47%Operating

13.71%Pre-Tax

12.37%Net

Valuation

9.33P/E

1.44P/B

1.15EV/Sales

7.50EV/EBITDA

-6.22P/FCF

Growth (CAGR)

39.42%Rev 3Yr

37.94%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

6.51%ROA

19.71%ROE

7.72%ROIC

Financial Health

$1.10BCash & Cash Equivalents

$1.33BNet Debt

159.41%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Sarepta Therapeutics Inc. trades at a P/E of 9.3 (undervalued) with strong ROE of 19.7%. 3Y revenue CAGR of 39.4% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Sarepta Therapeutics Inc. (ticker: SRPT) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $2.2B.

The current price is $23.08 with a P/E ratio of 9.33x and P/B of 1.44x.

ROE is 19.71% and operating margin is 11.47%. Annual revenue is $1.9B.